podcast about semaglutide and other GLP-1 weight-loss drugs are transforming bodies, but they’re also triggering thousands of adverse medical reports and major lawsuits. This episode uncovers alarming risks linked Surprising Benefits of Semaglutide Beyond

Multiple studies have demonstrated that water fasting for up to 21 days is well-tolerated, but none focused on patients with severe obesity (body mass index 40) or utilized treatment with glucagon-like peptide-1 receptor agonists (GLP-1)

The key is knowing how to ease into it, especially if you're dealing with side effects like nausea or fatigue

ADA is a member of scientific advisory boards for Hemanext Inc., Macopharma Inc

FDA-approved brand Wegovy runs $199 intro or $349 ongoing through NovoCare self-pay

The incidence of cholelithiasis and cholecystitis was higher in WEGOVY injection-treated pediatric patients aged 12 years and older than in WEGOVY injection-treated adults